2024 ICD-10-CM Diagnosis Code C40.11

Malignant neoplasm of short bones of right upper limb

  • C40.11 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
  • The 2024 edition of ICD-10-CM C40.11 became effective on October 1, 2023.
  • This is the American ICD-10-CM version of C40.11 – other international versions of ICD-10 C40.11 may differ.

The following code(s) above C40.11 contain annotation back-references

 that may be applicable to C40.11:

  • C00-D49  Neoplasms
  • C40-C41  Malignant neoplasms of bone and articular cartilage
  • C40  Malignant neoplasm of bone and articular cartilage of limbs

Approximate Synonyms

  • Bone cancer, bilateral hands
  • Bone cancer, right hand
  • Chondrosarcoma, bilateral hands
  • Chondrosarcoma, r hand
  • Ewings sarcoma, bilateral hands
  • Ewings sarcoma, r hand
  • Osteosarcoma, bilateral hands
  • Osteosarcoma, r hand
  • Primary chondrosarcoma of bilateral hands
  • Primary chondrosarcoma of right hand
  • Primary ewing’s sarcoma of bilateral hands
  • Primary ewing’s sarcoma of right hand
  • Primary malignant neoplasm of bone of bilateral hands
  • Primary malignant neoplasm of bone of right hand
  • Primary osteosarcoma of bilateral hands
  • Primary osteosarcoma of right hand

ICD-10-CM C40.11 is grouped within Diagnostic Related Group(s) (MS-DRG v41.0):

  • 542 Pathological fractures and musculoskeletal and connective tissue malignancy with mcc
  • 543 Pathological fractures and musculoskeletal and connective tissue malignancy with cc
  • 544 Pathological fractures and musculoskeletal and connective tissue malignancy without cc/mcc

Convert C40.11 to ICD-9-CMCode History

  • 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
  • 2017 (effective 10/1/2016): No change
  • 2018 (effective 10/1/2017): No change
  • 2019 (effective 10/1/2018): No change
  • 2020 (effective 10/1/2019): No change
  • 2021 (effective 10/1/2020): No change
  • 2022 (effective 10/1/2021): No change
  • 2023 (effective 10/1/2022): No change
  • 2024 (effective 10/1/2023): No change